Large-scale testing (Phase 3)Study completedNCT01229397
What this trial is testing
Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V
Who this might be right for
Influenza
Crucell Holland BV 205